Patent Expirations Pose Challenge to Pharmaceutical Companies in 2011

 Indianapolis — The New York Times reported this week that the pharmaceutical industry may lose billions as a result of the patent expirations in 2011. The article notes that many pharmaceutical companies may not have enough new drugs in research in development to replace the income lost due to these expirations. The Indiana’s Eli Lilly is mentioned, specifically noting that Lilly’s setback the development of an Alzheimer’s drug.